Time-dependent Nephrotoxicity Associated with Daily Administration of Cisplatin in Mice

• Published in: Journal of pharmacy and pharmacology 2000-12, Vol.52 (12), p.1499-1504
• Main Authors: TO, HIDETO, KIKUCHI, ATSUMI, TSURUOKA, SHUICHI, SUGIMOTO, KOICHI, FUJIMURA, AKIO, HIGUCHI, SHUN, KAYAMA, FUJIO, HARA, KYOKO, MATSUNO, KOJI, KOBAYASHI, EIJI
• Format: Article
• Language: English
• Subjects: Animals; Antineoplastic Agents - administration & dosage; Antineoplastic Agents - adverse effects; Antineoplastic Agents - pharmacokinetics; Biological and medical sciences; Blood Urea Nitrogen; Body Weight - drug effects; Circadian Rhythm; Cisplatin - administration & dosage; Cisplatin - adverse effects; Cisplatin - blood; Creatinine - blood; Drug Administration Schedule; Drug toxicity and drugs side effects treatment; Injections, Intraperitoneal; Interleukin-6 - metabolism; Kidney - drug effects; Kidney - metabolism; Kidney - pathology; Kidney Diseases - chemically induced; Lipopolysaccharides - pharmacology; Liver - drug effects; Liver - metabolism; Male; Medical sciences; Mice; Mice, Inbred BALB C; Pharmacology. Drug treatments; Time Factors; Tissue Distribution; Toxicity: urogenital system
• ISSN: 0022-3573; 2042-7158
• DOI: 10.1211/0022357001777711

The chronopharmacokinetics and chronopharmacodynamics of cisplatin were studied in a mouse model to reveal the mechanisms of dosing time‐dependent nephrotoxicity induced by daily administration. Chronotoxicity was tested by daily intraperitoneal injections of cisplatin (6 mg kg−1) for 5 days at four time points (0400, 1000, 1600 and 2200h) in BALB/c mice (n = 6 in each group). After following the changes in body weight, serum concentrations of blood urea nitrogen (BUN) and creatinine obtained on day 6 were compared. In conclusion, chrononephrotoxicity induced by daily cisplatin administration does not only depend on cisplatin accumulation, but might also depend on kidney sensitivity to diurnal variations in inflammatory reaction without direct cisplatin toxicity. The results showed diurnal variations in cisplatin toxicity, with the 0400 and 1600h time points the best and the worst, respectively. We then measured platinum concentrations in blood, liver and kidney and compared the results of the 0400 and 1600 h groups (n = 4 in each group). Kidney sensitivity to cisplatin alone, lipopolysaccharide (LPS) alone, cisplatin with LPS and saline (control) were also measured using a tissue culture system (a measurement system of interleukin‐6 (IL‐6) production) between the 0400 and the 1600h groups (n = 4 in each group). These results showed no significant difference in platinum accumulation between the two groups. IL‐6 production was higher in the 1600h group than in the 0400h group after saline injection alone (P < 0.05). Cisplatin treatment alone did not increase IL‐6 production. However, IL‐6 levels were markedly augmented by cisplatin with LPS.